Latest Anti-diabetic medication Stories
The Actos Lawsuit Purports Takeda Pharmceuticals Knew Long-Term Use Of The Medication Could Potentially Lead To Bladder Cancer. Columbus, OH (PRWEB) October
Expresses Continued Confidence in ACTOS DEERFIELD, Ill., Oct. 3, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc.
-FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications.
Diabetes Miracle Cure reviews have been flooding the Internet and HealthyandFitZone.com reveals the truth about this method to cure diabetes permanently, without the need of using any outdated
Culinary Expert Visits San Diego County on September 20 to Help Educate At-Risk Population About Ingredients for Successful Blood Sugar Management WHITEHOUSE STATION, N.J.,
- Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise INDIANAPOLIS, Sept.
- Data indicate 58% non-adherence to second-line treatments in T2D patients, significantly higher than patients report and prescribers perceive VIENNA, Sept.
The Firm is evaluating Byetta lawsuits on behalf of individuals who developed pancreatitis, pancreatic cancer or thyroid cancer allegedly due to their use of Byetta or other incretin mimetic Type
- Oral presentation 9/19: interim Phase 3 results for ITCA 650 among patients with high baseline (HBL) HbA1c levels between 10-12% showed dramatic HbA1c reductions, even in patients with high HbA1c
Takeda Stresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Sept.
- In medieval musical notation, a sign or neume denoting a shake or trill.